Subscribe to RSS
![](/products/assets/desktop/img/oa-logo.png)
DOI: 10.1055/a-1490-9234
Detection of SARS-CoV-2 in the gastrointestinal tract among patients with negative nasopharyngeal COVID-19 testing prior to endoscopy
![](https://www.thieme-connect.de/media/10.1055-s-00025476/202108/lookinside/thumbnails/2291_10-1055-a-1490-9234-1.jpg)
Abstract
Background and study aims The clinical significance of SARS-CoV-2 RNA in the stool remains unclear. We aimed to determine whether SARS-CoV-2 is detected via real-time reverse transcriptase polymerase chain reaction (rRT-PCR) in the gastrointestinal tracts of patients scheduled for endoscopy and if the virus obtained from these clinical specimens could be isolated in culture.
Patients and methods All patients underwent symptom screening and had negative nasopharyngeal testing for SARS-CoV-2 within 72 hours of their scheduled procedure. Study samples were collected via nasopharyngeal swab, rectal swab, and fluid from the upper gastrointestinal tract and/or colon based on their endoscopic procedure(s). Samples were tested for SARS-CoV-2 via rRT-PCR. SARS-CoV-2 positive specimens were isolated and cultured in Vero-E6 cells.
Results 243 patients (mean age 63.1 years;54.3 % men) were enrolled from July 15, 2020 to September 2, 2020. SARS-CoV-2 testing was performed from 242 (99.6 %) nasopharyngeal, 243 (100 %) rectal, 183 (75.3 %) upper gastrointestinal tract and 73 (30 %) colon samples. SARS-CoV-2 RNA was detected in the nasopharynx and gastrointestinal specimens in one patient (0.4 %). After a 14-day incubation period, there was no evidence of virus growth in cells incubated with any of these specimens.
Conclusions SARS-CoV-2 was rarely detected in the gastrointestinal tract of patients with negative nasopharyngeal testing prior to endoscopy. No live virus was detected by culture, further highlighting that presence of viral genome on its own is not sufficient proof of infectivity. PCR-based screening provides limited insight into virus infectivity and its results should be interpreted carefully as to avoid unnecessary delays in clinical care or inadvertent risk exposure.
Publication History
Received: 01 February 2021
Accepted: 31 March 2021
Article published online:
16 July 2021
© 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Johns Hopkins Coronavirus Resource Center. https://coronavirus.jhu.edu/map.html [Accessed December 19th, 2020]
- 2 Sultan S, Lim JK, Altayer O. et al. AGA Institute Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic. Gastroenterology 2020; 159: 739-758.e4
- 3 European Centre for Disease Prevention and Control – Latest evidence on COVID-19. https://www.ecdc.europa.eu/en/covid-19/latest-evidence [Accessed September 28th, 2020]
- 4 World Health Organization (WHO). Q&A: How is COVID-19 transmitted?. https://www.who.int/news-room/q-a-detail/q-a-how-is-covid-19-transmitted [Accessed September 28th, 2020]
- 5 He X, Lau EHY, Wu P. et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med 2020; 26: 672-675
- 6 AGA/DHPA joint guidance for resuming elective endoscopy during COVID-19 pandemic. https://gastro.org/news/aga-dhpa-release-guidance-for-resuming-elective-endoscopy Accessed August 26th, 2020
- 7 Cheung KS, Hung IFN, Chan PPY. et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology 2020; 159: 81-95
- 8 Centers for Disease Control and Prevention (CDC) guidelines for clinical specimen collection. https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html [Accessed on May 26th, 2020]
- 9 Lednicky JA, Lauzardo M, Hugh Fan Z. et al. Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients. Int j infect Dis 2020; 100: 476-482
- 10 Centers for Disease Control and Prevention – Novel Coronavirus (2019-nCoV) Real-time RT-PCR Primers and Probes. https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-panel-primer-probes.html [Accessed on October 2nd, 2020]
- 11 University of Florida home care instructions for people who have or might have COVID-19. https://bridge.ufhealth.org/response/wp-content/uploads/sites/51/2020/03/3161744-COMM-COVID-19_HomeCare-Instructions_FHR_F4.pdf [Accessed on August 29th, 2020]
- 12 Guidance for resuming GI endoscopy and Practice Operations after the COVID-19 Pandemic. https://www.asge.org/docs/default-source/default-document-library/asge-guidance-for-reopeningl_4-28-2020.pdf [Accessed on September 1st, 2020]
- 13 The ACG Endoscopy Resumption Task Force: Guidance on Safely Reopening Your Endoscopy Center. https://webfiles.gi.org/docs/policy/2020resuming-endoscopy-fin-05122020.pdf [Accessed on September 1st, 2020]
- 14 Tian Y, Rong L, Nian W. et al. Gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther 2020; 51: 843-851
- 15 Forde JJ, Goldberg D, Sussman D. et al. Yield and implications of pre-procedural COVID-19 PCR testing on routine endoscopic practice. Gastroenterology 2020; 1538: 1538-1540
- 16 Bowyer B, Thurkral C, Patel S. et al. Outcomes of symptom screening and universal COVID-19 reverse transcriptase polymerase chain reaction testing before endoscopy in a community-based ambulatory surgery center. Gastrointest Endosc 2021; 93: 1060-1064.e1
- 17 Podboy A, Cholankeril G, Cianfichi L. et al. Implementation and impact of universal pre-procedural testing of patients for COVID-19 prior to endoscopy. Gastroenterology 2020; 17 S0016-5085(20)34819-8 DOI: 10.1053/j.gastro.2020.06.022.
- 18 Florida’s COVID-19 Data and Surveillance Dashboard for Alachua County. https://experience.arcgis.com/experience/96dd742462124fa0b38ddedb9b25e429 [Accessed on September 1st, 2020]
- 19 West CP, Montori VM, Sampathkumar P. COVID-19 testing: the threat of false-negative results. Mayo Clin Proc 2020; 95: 1127-1129
- 20 Fang Y, Zhang H, Xie J. et al. Sensitivity of CT for COVID-19; comparison to RT-PCR. Radiology 2020; 296: E115-E117
- 21 Wu Y, Guo C, Tang L. et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol 2020; 5: 434-435
- 22 Xiao F, Tang M, Zheng X. et al. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology 2020; 158: 1831-1833
- 23 Bonato G, Disocridi L, Mutgnani M. Faecal-oral transmission of SARS-CoV-2: practical implications. Gastroenterology 2020; S0016-5085
- 24 Grassia R, Testa S, Pan A. et al. SARS-CoV-2 and gastrointestinal tract: The dark side of the pandemic. Dig Liver Dis 2020; 52: 700-701
- 25 Woloshin S, Patel N, Kesselheim A. False negative tests for SARS-CoV-2 infection – challenges and implications. N Engl J Med 2020; 383: e38
- 26 Strong JE, Feldmann H. The crux of Ebola diagnostics. J Infect Dis 2017; 216: 1340-1342
- 27 Wölfel R, Corman VM, Guggemos W. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 2020; 581: 465-469
- 28 Bullard J, Dust K, Funk D. et al. Predicting infectious severe acute respiratory syndrome coronavirus 2 from diagnostic samples. Clin Infect Dis 2020; 71: 2663-2666
- 29 Zheng S, Fan J, Yu F. et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ 2020; 369: m1443
- 30 Zou L, Ruan F, Huang M. et al. SARS-CoV-2 Viral load in upper respiratory specimens of infected patients. N Engl J Med 2020; 19: 1177-1179
- 31 To KK, Tsang O, Leung WS. et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis 2020; 20: 565-574
- 32 Byrne AW, McEvoy D, Collins AB. et al. Inferred duration of infectious period of SARS-CoV-2: rapid scoping review and analysis of available evidence for asymptomatic and symptomatic COVID-19 cases. BMJ Open 2020; 10: e039856